Bangladesh Association of Pharmaceutical Industries

What Bangladesh Association of Pharmaceutical Industries does

The Bangladesh Association of Pharmaceutical Industries (BAPI) is the apex industry trade body representing pharmaceutical manufacturers in Bangladesh, founded in 1972 and headquartered in Dhaka. It represents 257 registered pharmaceutical companies that collectively fulfill 98% of Bangladesh's domestic medicinal requirement and export to 150+ countries including the USA, UK, Canada, Australia, Germany, and the EU, generating export earnings of approximately $169M. BAPI is led by an elected executive committee and operates as a coordination body rather than a commercial enterprise, with no disclosed revenue, pricing model, or direct product offering.

BAPI's core activities center on regulatory coordination, GMP advocacy, export promotion, and industry infrastructure development. It works closely with the Ministry of Health and Family Welfare, the Directorate General of Drug Administration (DGDA), the Bangladesh Export Promotion Bureau, and the Board of Investment. It organizes the Asia Pharma Expo annually since 2003, participates in global pharma events (CPhI Worldwide, CPhI Japan, CPhI India), and convenes annual general meetings where strategic positioning — most recently the Vision 2033 framework — is debated. The association also stewards the API Park industrial project, a 200-acre dedicated manufacturing zone backed by ~$300M in member investment commitments.

The business model is membership-based and event-funded; pricing is not publicly disclosed. Member companies include major manufacturers such as Beximco Pharmaceuticals, Square Pharmaceuticals, and Incepta Vaccine Ltd. The technology footprint of the represented industry spans conventional generics through to high-complexity products (insulin, hormones, anti-cancer formulations), with Incepta's vaccine bulk manufacturing facility signaling expansion into biologics. The defining structural advantage is the WTO TRIPS exemption for least-developed countries, which protects Bangladesh's ability to produce patented pharmaceuticals without prior consent until 2033.

Name

Bangladesh Association of Pharmaceutical Industries

Legal name

Bangladesh Association of Pharmaceutical Industries

Website

http://www.bapi-bd.com/

Company type

Private

Founded year

1972

Operating status

Operating

Headcount range

101–250 employees

Short description

Founded in 1972, the Bangladesh Association of Pharmaceutical Industries (BAPI) is the apex trade body representing 257 pharmaceutical manufacturers in Bangladesh, coordinating GMP compliance, export promotion, and the API Park industrial project. It supports an industry fulfilling 98% of domestic drug demand and exporting to 150+ countries.

Ownership category

akta.pro rank

Product category

Pharmaceutical Industry Association

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Health, Pharmaceuticals & Medical Devices Regulatory Cooperation (BPADANAJ)

akta.pro secondary industries

Small-Molecule API Commercial Manufacturing (HLAGAHAB), Pharmaceuticals & Biotechnology (EDABALAU)

Keywords

• Pharmaceutical trade association
• Industry advocacy
• Pharmaceutical manufacturing
• Pharma exports
• API park development

Headquarters

HQ city

Dhaka

HQ country

Bangladesh

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Distribution channels2 records

Marketing channels5 records

Core offering

Bangladesh Association of Pharmaceutical Industries (BAPI) is a trade association founded in 1972 that represents and coordinates Bangladesh's pharmaceutical manufacturing sector. It serves as the collective voice of 257 registered pharmaceutical companies, supporting domestic production that meets 98% of the country's medicinal requirements and promotes pharmaceutical exports to 150+ countries. The association also drives industry development initiatives, including the API Park project on 200 acres to build active pharmaceutical ingredient manufacturing capacity.

Product overview

Bangladesh Association of Pharmaceutical Industries (BAPI) is an industry trade association and apex body representing pharmaceutical companies in Bangladesh, not a product company. BAPI does not offer commercial products or services. Its activities include organizing industry events such as the Asia Pharma Expo, advocating for pharmaceutical manufacturing standards (GMP), managing the API Park industrial development project, providing a members directory, and publishing industry news. The organization serves as a representative body for the pharmaceutical sector rather than as a provider of products or technology solutions.

Differentiator

Problem solved

Functional benefit

Products and services

• Membership and Industry Representation
• API Park Development Initiative

Quantifiable outcome

• Bangladesh pharmaceutical industry supplies 98% of domestic medicinal requirements
• +2 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Seven partnerships are on record, tiered core and moderate.

• Ministry of Health and Family Welfare, BangladeshcoreOthersGovernment ministry providing regulatory oversight and policy direction for the pharmaceutical sector in Bangladesh
• Directorate General of Drug Administration (DGDA)coreOthersRegulatory authority responsible for drug administration and GMP compliance in Bangladesh. BAPI works closely with DGDA to promote understanding of good manufacturing practices
• Bangladesh Export Promotion BureaucoreGTM or Marketing PartnerGovernment body facilitating export promotion activities. BAPI coordinates with EPB for export documentation and trade facilitation
• Federation of Bangladesh Chambers of Commerce and Industry (FBCCI)moderateGTM or Marketing PartnerConfederation of trade associations working on trade promotion and business development
• Asia Pharma ExpocoreStrategic or Co-development PartnerBAPI has been successfully organizing the Asia Pharma Expo since 2003, providing international exhibition platform for complete pharma manufacturing technologies
• Board of Investment BangladeshmoderateStrategic or Co-development PartnerGovernment investment promotion agency supporting foreign and local investment in Bangladesh
• World Trade Organization (WTO)coreStrategic or Co-development PartnerWTO TRIPS agreement provides Bangladesh and LDCs exemption from patents and data protection for pharmaceutical products till 2033, enabling generic drug production

Scale indicators13 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• European Federation of Pharmaceutical Industries and Associations (EFPIA): The leading European pharma industry association representing innovative and generic manufacturers across the EU. Direct comparable to BAPI as a regional pharmaceutical industry coordinating body working with regulatory authorities on GMP and market access.
• Association for Accessible Medicines (AAM): US-based trade association for generic and biosimilar manufacturers. Peer to BAPI as an industry body promoting affordable generic medicines, regulatory compliance, and market access for cost-competitive generic producers.
• Indian Pharmaceutical Alliance (IPA): India's premier pharma industry association representing leading domestic generic manufacturers. Direct peer to BAPI as an apex national industry body coordinating regulatory policy, GMP compliance, and export promotion for South Asian generic manufacturers.
• Pharmaceutical Research and Manufacturers of America (PhRMA): Leading US pharmaceutical industry association representing research-based biopharmaceutical companies. Comparable to BAPI as a major national pharma industry trade body that engages in regulatory policy, international trade advocacy, and standards promotion.
• Japan Pharmaceutical Manufacturers Association (JPMA): Japan's primary pharmaceutical industry association representing research-oriented and generic manufacturers. Peer to BAPI as an apex national pharma trade body engaged in international regulatory cooperation and export promotion.
• International Federation of Pharmaceutical Manufacturers and Associations (IFPMA): Global pharmaceutical industry federation based in Geneva. Direct peer as an international pharma industry body that coordinates policy, regulatory cooperation, and TRIPS-related advocacy, which is core to BAPI's mandate through 2033.
• Pharmaceutical Manufacturers Association of India (PMAI): Another major Indian pharmaceutical industry trade body. Comparable to BAPI as a national industry association advocating for pharmaceutical manufacturers on regulatory, trade, and policy matters in a similarly structured South Asian market.

Regional players

• Korean Pharmaceutical Association (KPA): Major pharmaceutical trade body in South Korea representing manufacturers and pharmacists. Comparable to BAPI as a national pharmaceutical industry association in an Asian emerging market focused on domestic self-sufficiency and export growth.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/BAPI61703299
• Facebookfacebook.com/BangladeshAssociationOfPharmaceuticalIndustries
• LinkedInlinkedin.com/company/bangladesh-association-of-pharmaceutical-industries

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bangladesh Association of Pharmaceutical Industries